HDL-C

There are 411 papers on HDL-C in aging research: 84 trials and 239 observational studies in people, 16 in animals, 67 reviews.

Biomarker

411 papers study it1,133 more mention it148 findings

171 new papers in 30 daysSee all 1,544 papers on HDL-C

At a glance

Extremely low HDL-C is associated with higher mortality than markedly low levels in a human study. Human cohorts link higher HDL-C with lower coronary artery disease risk in men but higher fracture risk, while cognitive associations include an inverted U-shaped relationship in women. Trials report HDL-C increases with exercise and obicetrapib, but no clear effect with time-restricted feeding.

148 findings in 115 papers from 1999 to 2026, 28 of them since April 2026

“lower posttreatment HDL-C (β = -0.121; P = .004)”
Preliminary Evidence for the Association of APOB rs1042034 With Short-Term Statin-Induced Lipid Lowering: An Exploratory Study in VietnamJournal of cardiovascular pharmacology and therapeutics2026doi:10.1177/10742484261428536
  • Human trial84
  • Humans239
  • Animals16
  • In silico3

Interventions

43

Obicetrapib

upin humans4+125%

4 studies
  1. Obicetrapib increases HDL-C in humans.

    “Obicetrapib also showed substantial improvements in HDL-C and ApoB.”

    Human trial

    Efficacy and Safety of Oral Non-Statin Lipid-Lowering Therapies in Dyslipidaemia: A Systematic Review and Network Meta-Analysis

    Endocrinology, diabetes & metabolism

  2. Obicetrapib increases HDL-C in humans (MD +147.98).

    “HDL cholesterol [MD, +147.98 (95% CI, 129.23-166.54), P < 0.001]”

    Human trialn = 3,512

    Lipid-Lowering Efficacy and Safety of Obicetrapib Alone and as an Add on Therapy: A Meta-Analysis of Randomized Controlled Trials

    Cardiology in review

  3. Obicetrapib increases HDL-C in humans (atherosclerosis cardiovascular disease) (+125%).

    “Obicetrapib significantly lowered LDL‐C by 33% and increased HDL‐C by 125% relative to placebo.”

    Human trialatherosclerosis cardiovascular disease12 monthsn = 1,727

    Effects of Obicetrapib, a Potent Oral CETP Inhibitor, on Alzheimer's Disease Biomarkers in 1727 Patients with cardiovascular disease

    AAIC 2025 abstract

  4. Obicetrapib increases HDL-C in humans (on background statin therapy) (MD 156.21%; 95% CI 146.40% to 166.02%).

    “HDL-C levels in the obicetrapib group were significantly higher (MD: 156.21%; 95% CI: 146.40% to 166.02%; p<0.00001)”

    Human trialon background statin therapy10 mg

    Evaluating Lipid-Lowering Efficacy Of Obicetrapib: An Updated Meta-Analysis of Clinical Trials

    AHA Scientific Sessions 2025 abstract

More on Obicetrapib

Exercise

upin humans3

3 studies
  1. Exercise increases HDL-C in obese T2DM patients (MD = 0.12, 95% CI [0.05, 0.18]).

    “HDL-C increased markedly (MD = 0.12, 95% CI [0.05, 0.18]”

    Reviewin obese T2DM patients

    Exercise modalities for adults with type 2 diabetes mellitus and obesity: comparative effects on visceral fat, metabolism, and inflammatory markers from a network meta-analysis

    Frontiers in immunology

  2. Exercise increases HDL-C in humans (individuals with overweight or obesity) (Hedges' g = 0.51).

    “moderate improvements in triglycerides (Hedges' g = -0.55), total cholesterol (Hedges' g = -0.23), and high-density lipoprotein cholesterol (HDL-C; Hedges' g = 0.51)”

    Reviewindividuals with overweight or obesity

    The impact of maximal fat oxidation intensity exercise on glucose and lipid metabolism in individuals with overweight or obesity: A systematic review and meta-analysis

    Biology of sport

  3. Exercise increases HDL-C in humans.

    “exercise increases HDL-cholesterol and reduces the triglyceride levels.”

    Review

    The role of cardiorespiratory fitness on plasma lipid levels

    Expert review of cardiovascular therapy

More on Exercise

Folic acid

upin humans1

1 study
  1. Folic acid increases HDL-C in humans with resistance training (+0.21 ± 0.24 mmol/L vs -0.01 ± 0.12 mmol/L).

    “The overall group effect was significant for HDL-C only (F = 3.43, P = 0.027).”

    Human trialwith resistance training9 weeksmalesn = 40

    Effects of folic acid combined with resistance training on body composition and blood biomarkers in adult males

    Journal of the International Society of Sports Nutrition

  2. Folic acid increases HDL-C in humans (combined with resistance training) (+0.21 ± 0.24 mmol/L).

    “HDL-C increased more in the RF (+0.21 ± 0.24 mmol/L) than in the control (-0.01 ± 0.12 mmol/L; P < 0.01) and FA (+0.02 ± 0.16 mmol/L; P < 0.05).”

    Human trialcombined with resistance training0.4 mg daily8 weeksmalesn = 40

    Effects of folic acid combined with resistance training on body composition and blood biomarkers in adult males

    Journal of the International Society of Sports Nutrition

More on Folic acid

Physical activity promotion program

upin humans1

1 study
  1. Physical activity promotion program increases HDL-C in humans.

    “For the 1st vs. 3rd pairwise comparison, significant differences were demonstrated in WHtR, HDL-C, cognitive function for attention and executive function (i.e., SCWT), and MVPA ≥ 150 min/wk, and sitting time.”

    Human trial6 monthsn = 99

    Effect of smartwatch and break-reminder with exercises application on cardiometabolic risk and cognition in office workers: a single group pre-posttest design

    BMC public health

  2. Physical activity promotion program increases HDL-C in humans (+2.84 mg/dL (95% CI: +0.82 to + 4.87)).

    “HDL-C levels increased significantly by + 2.84 mg/dL (95% CI: +0.82 to + 4.87) at six months compared with baseline.”

    Human trial6 monthsn = 87

    Effect of smartwatch and break-reminder with exercises application on cardiometabolic risk and cognition in office workers: a single group pre-posttest design

    BMC public health

More on Physical activity promotion program

Time-restricted feeding

no changein humans1upin humans1

1 study
  1. Time-restricted feeding showed no clear effect on HDL-C in humans.

    “Repeated measures ANOVA revealed no significant group-by-time interactions for both TC, TG, HDL-C and LDL-C.”

    Human trialsix weeksn = 17

    Impact of 16/8 time-restricted eating on body composition and lipolytic hormone regulation in female DanceSport dancers

    Journal of the International Society of Sports Nutrition

  2. Time-restricted feeding increases HDL-C in humans.

    “HDL-C levels significantly increased in the TRE group (p < 0.05) following the 6-week intervention”

    Human trial6 weeksfemalesn = 10

    Impact of 16/8 time-restricted eating on body composition and lipolytic hormone regulation in female DanceSport dancers

    Journal of the International Society of Sports Nutrition

More on Time-restricted feeding

Walking

upin humans1

1 study
  1. Walking increases HDL-C in humans.

    “As shown in Table and Fig., there were significant interactions between systolic pressure (P = 0.036), diastolic pressure (P = 0.036), HDL-C (P < 0.001), LDL-C (P < 0.001), and HbA1c (P = 0.001).”

    Human trial24-week exercise programme and the 12-week retention periodfemalesn = 168

    Training and retention effects of paced and music-synchronised walking exercises on pre-older females: an interventional study

    BMC geriatrics

  2. Walking increases HDL-C in humans (P < 0.001).

    “All walking conditions improved high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol, step length, maximum oxygen consumption (VO2max), and oxidative capacity at anaerobic threshold (all P < 0.001)”

    Human trial24 weeksfemalesn = 78

    Training and retention effects of paced and music-synchronised walking exercises on pre-older females: an interventional study

    BMC geriatrics

More on Walking

Dehydroepiandrosterone

no changein humans1downin humans1

1 study
  1. Dehydroepiandrosterone showed no clear effect on HDL-C in humans (WMD 0.13 mg/dl, 95% CI: -1.4 to 1.7).

    “not in males (WMD: 0.13 mg/dl, 95% CI: -1.4 to 1.7)”

    Reviewmales

    Effects of dehydroepiandrosterone (DHEA) supplementation on the lipid profile: A systematic review and dose-response meta-analysis of randomized controlled trials

    Nutrition, metabolism, and cardiovascular diseases : NMCD

  2. Dehydroepiandrosterone decreases HDL-C in humans (WMD -5.1 mg/dl, 95% CI: -7.2 to -3).

    “a significant reduction in HDL-C values was observed in studies comprising women (WMD: -5.1 mg/dl, 95% CI: -7.2 to -3)”

    Reviewfemales

    Effects of dehydroepiandrosterone (DHEA) supplementation on the lipid profile: A systematic review and dose-response meta-analysis of randomized controlled trials

    Nutrition, metabolism, and cardiovascular diseases : NMCD

More on Dehydroepiandrosterone

Aerobic exercise

upin mice1

1 study
  1. Aerobic exercise increases HDL-C in mice (Compared with age-matched sedentary mice).

    “HDL-C concentrations were significantly increased in the 36E1 group compared with the 36C group”

    AnimalsCompared with age-matched sedentary micemoderate-intensity continuous aerobic exerciseserum3 times/week, 50 min/session6–36, 6–60, or 6–72 weeks of age

    Effects of aerobic exercise on exercise capacity and blood lipid metabolism in mice at different stages of the life cycle

    Chinese Journal of Gerontology

More on Aerobic exercise

Cetp inhibitors

upin reviews1

1 study
  1. Cetp inhibitors increase HDL-C.

    “Inhibition of CETP can increase high-density lipoprotein cholesterol (HDL-C) while reducing low-density lipoprotein cholesterol (LDL-C).”

    Review

    Progress on cholesteryl ester transfer protein-related genes and CETP inhibitor therapy

    Yi chuan = Hereditas

More on Cetp inhibitors

Vegetarian diet

downin humans1

1 study
  1. Vegetarian diet is linked with lower HDL-C in humans (β = -3.4040, p < 0.0001).

    “However, a vegetarian diet was associated with lower HDL-C (β = -3.4040, p < 0.0001).”

    Humans>6 monthsn = 9,263

    Gene-diet interaction between CETP rs3764261 and vegetarian diet on HDL-C levels: evidence for precision nutrition from the Taiwan Biobank

    Frontiers in nutrition

More on Vegetarian diet

Herbal supplements

downin humans1

1 study
  1. Herbal supplements prevent HDL-C in humans (pesco-vegetarian diet).

    “our study suggests that ginger and curcumin supplements may have blunted the decrease in HDL-C levels associated with vegetarian diets.”

    Human trialpesco-vegetarian dietblood1 or 2 doses (500 mg)1 week

    Dietary intake and blood biomarker changes with a one-week pesco-vegetarian diet intervention supplemented with varying dose of ginger and curcumin: A single-blinded randomized clinical trial

    Nutrition and health

More on Herbal supplements

Pesco-vegetarian diet

downin humans1

1 study
  1. Pesco-vegetarian diet decreases HDL-C in humans (without ginger and curcumin supplementation).

    “a significant decrease in blood high-density lipoprotein cholesterol (HDL-C) levels was observed in the 0 dose group but not in 1 or 2 dose groups.”

    Human trialwithout ginger and curcumin supplementationblood0 dose1 week

    Dietary intake and blood biomarker changes with a one-week pesco-vegetarian diet intervention supplemented with varying dose of ginger and curcumin: A single-blinded randomized clinical trial

    Nutrition and health

More on Pesco-vegetarian diet

Rosuvastatin + ezetimibe

upin humans1

1 study
  1. Rosuvastatin + ezetimibe increases HDL-C in humans (elderly patients with atherosclerosis) (+18.4%, p<0.01).

    “an 18,4% increase in HDL-C (p<0,01)”

    Human trialelderly patients with atherosclerosisrosuvastatin 20 mg + ezetimibe 10 mg/day vs rosuvastatin 20 mg/day6 monthsn = 739

    Using artificial intelligence technologies for phenotyping and optimization of combination lipid-lowering therapy in elderly patients with atherosclerosis (PHOENIX Study)

    Russian Journal of Cardiology

More on Rosuvastatin + ezetimibe

Movie-theater-style meal

downin humans1

1 study
  1. Movie-theater-style meal decreases HDL-C in humans.

    “while HDL-C decreased (ptime's ≤ 0.05)”

    Human trialn = 10

    The "Movie Theater" Study: Acute Cardiometabolic Effects of a Cinema-Style Meal

    Metabolites

More on Movie-theater-style meal

Diet

upin humans1+11%

1 study
  1. Diet increases HDL-C in humans (hypercholesterolemia) (+11%).

    “Both groups exhibited a significant increase in HDL-C (+11%) and folic acid (+64%), along with a 35% reduction in LDH.”

    Human trialhypercholesterolemia6 monthsn = 81

    Effect of a Chilean diet supplemented with Gevuina avellana molina versus a low-fat diet on cardiometabolic, oxidative stress, and inflammatory biomarkers in Chilean adults with hypercholesterolemia: A randomized controlled trial

    Nutrition, metabolism, and cardiovascular diseases : NMCD

More on Diet

All 43

Effects

10

Cardiovascular disease

mediatesin humans2

2 studies
  1. HDL-C is linked with cardiovascular disease in humans (exposure to BPA, ΣDEHP, or PrP) (20.8% for BPA, 39.6% for ΣDEHP, 14.1% for PrP).

    “In lipid mediation analyses, the estimated HDL-C-related mediation proportions were 20.8% for BPA, 39.6% for ΣDEHP, and 14.1% for PrP”

    Humansexposure to BPA, ΣDEHP, or PrPn = 3,831

    Cardiovascular risks of plastic-associated chemicals: Integrating mixture modeling and SHAP-explained machine learning to unravel linear and non-linear associations

    Environmental research

  2. HDL-C is linked with cardiovascular disease in humans (total effects of PM2.5, BC, SO42−, and OM on CVD) (10.46% to 39.35% mediated).

    “high-density lipoprotein-cholesterol (HDL-C) played a mediating role in the total effects, accounting for 10.46%, 24.96%, 39.35%, and 24.74% of PM2.5, BC, SO42−, and OM, respectively”

    Humanstotal effects of PM2.5, BC, SO42−, and OM on CVDn = 21,102

    Effects of long-term time-weighted fine particulate matter components and ozone exposure on incident cardiovascular disease and the mediating roles of metabolic risk factors

    Nutrition, metabolism, and cardiovascular diseases : NMCD

More on Cardiovascular disease

Cognitive function

upin humans1no changein humans1

2 studies
  1. HDL-C is linked with better cognitive function in humans (β = 0.45, 95% CI 0.29-0.62, p < 0.001).

    “In fully adjusted linear models, men showed consistently positive associations across all cognitive domains, including delayed recall (β = 0.10, 95% CI 0.04-0.17, p < 0.001), immediate recall (β = 0.06, 95% CI 0.00-0.12, p = 0.047), verbal fluency (β = 0.20, 95% CI 0.14-0.26, p < 0.001), processing speed (β = 0.09, 95% CI 0.05-0.14, p < 0.001), and overall composite score (β = 0.45, 95% CI 0.29-0.62, p < 0.001).”

    Humansmalesn = 2,777

    Investigating causal effects of HDL-C on cognitive function through cross-sectional and Mendelian randomization analyses: concentration-response patterns and clues for Alzheimer's disease prevention

    BioData mining

  2. HDL-C was not clearly linked with cognitive function in humans (β = -0.008; P > 0.05).

    “higher baseline HDL-C levels did not significantly predict cognitive performance or depression 4 years later”

    Humans4 yearsn = 4,302

    Cognitive impairment and depression precede increased HDL-C levels in middle-aged and older Chinese adults: cross-lagged panel analyses

    Lipids in health and disease

Subclinical carotid atherosclerosis

downin humans1

1 study
  1. HDL-C is linked with less subclinical carotid atherosclerosis in prediabetic subgroup.

    “factors independently associated with SCAS included age, sex, 2 h postprandial glucose, total cholesterol, and HDL-C (protective)”

    Humansin prediabetic subgroup

    Clinical characteristics of subclinical carotid atherosclerosis in middle-aged and elderly populations with different glucose metabolism statuses: a cross-sectional study

    Frontiers in cardiovascular medicine

More on Subclinical carotid atherosclerosis

Depression

mediatesin humans1

1 study
  1. HDL-C is linked with depression in humans (mediation of the GDF15 association with depression) (7.51% of the association with depression).

    “High-density lipoprotein cholesterol (HDL-C) accounted for an estimated 7.51% of the association with depression”

    Humansmediation of the GDF15 association with depression

    Peripheral GDF15 as an early biomarker for brain disorders: A large prospective cohort study

    Progress in neuro-psychopharmacology & biological psychiatry

More on Depression

Diabetes mellitus

mediatesin humans1

1 study
  1. HDL-C is linked with diabetes mellitus in humans (prediabetes) (14.47% of overall effect).

    “high-density lipoprotein (HDL), triglycerides (TG), and C-reactive protein (CRP) partially mediated the effect between RMS and prediabetes progression, accounting for 14.47%, 4.41%, and 0.21% of the overall effect”

    Humansprediabetesn = 3,250

    Skeletal muscle health and the development of prediabetes in middle-aged and older adults: mediated by inflammation and lipid indices

    Diabetes & metabolic syndrome

More on Diabetes mellitus

Mortality

mediatesin humans1

1 study
  1. HDL-C is linked with mortality in humans (low BMI and mortality in type 2 diabetes mellitus) (PE = –111.99%, βACME = 1.44, 95% CI: 1.33 ~ 1.56).

    “Mediation analysis demonstrated significant negative mediation for TC (proportion mediated, PE = –16.68%), HDL-C (PE = –111.99%), and LDL-C (PE = –4.12%), with HDL-C showing the strongest masking effect”

    Humanslow BMI and mortality in type 2 diabetes mellitusn = 372,559

    Low BMI predicts mortality in T2DM older adults: cholesterol parameters demonstrate negative mediation

    Diabetology & metabolic syndrome

PhenoAge

downin humans1

1 study
  1. HDL-C is linked with lower PhenoAge in humans (1.60 < HDL-C ≤ 3.90 mmol/L combined with abdominal SFA ≤ 3.137 m2 or VFA ≤ 0.925 m2).

    “whereas 1.60 < HDL-C ≤ 3.90 mmol/L combined with abdominal SFA ≤ 3.137 m2 or VFA ≤ 0.925 m2 decelerated PhenoAge.”

    Humans1.60 < HDL-C ≤ 3.90 mmol/L combined with abdominal SFA ≤ 3.137 m2 or VFA ≤ 0.925 m2

    The association of visceral and subcutaneous fat areas with phenotypic age in non-elderly adults, mediated by HOMA-IR and HDL-C

    Lipids in health and disease

More on PhenoAge

PhenoAgeAccel

mediatesin humans1

1 study
  1. HDL-C is linked with PhenoAgeAccel in humans (21.7% mediated).

    “accounting for 21.7% of the relationship between VFA and PhenoAgeAccel”

    Humans

    The association of visceral and subcutaneous fat areas with phenotypic age in non-elderly adults, mediated by HOMA-IR and HDL-C

    Lipids in health and disease

More on PhenoAgeAccel

Depressive symptoms

no changein humans1

1 study
  1. HDL-C was not clearly linked with depressive symptoms in humans (β = 0.023; P > 0.05).

    “higher baseline HDL-C levels did not significantly predict cognitive performance or depression 4 years later”

    Humans4 yearsn = 4,302

    Cognitive impairment and depression precede increased HDL-C levels in middle-aged and older Chinese adults: cross-lagged panel analyses

    Lipids in health and disease

Stroke

no changein humans1OR 1.29

1 study
  1. HDL-C was not clearly linked with stroke in humans (HDL-C > 1.55 mmol/L) (OR 1.29, 95% CI 0.79-2.09).

    “above 1.55 mmol/L, the incidence of stroke was not significant (OR = 1.29, 95% CI: 0.79-2.09, p>.05).”

    HumansHDL-C > 1.55 mmol/L

    The association between HDL-C and stroke in the middle-aged and elderly: A cross-sectional study

    Brain and behavior

More on Stroke

Upstream

2

APOE ε4 allele

downin humans1

1 study
  1. APOE ε4 allele is linked with lower HDL-C in humans (carriers versus noncarriers).

    “the ε4 carriers were lower than noncarriers in middle-aged males (P < 0.05)”

    Humanscarriers versus noncarriersmales

    The effects of genetic polymorphisms of APOE on circulating lipid levels in middle-aged and elderly chinese Fujian Han population: toward age- and sex-personalized management

    Lipids in health and disease

APOE ε2 allele

upin humans1

1 study
  1. APOE ε2 allele is linked with higher HDL-C in humans (carriers versus noncarriers).

    “the ε2 carriers were higher than the noncarriers in middle-aged females (all P < 0.05)”

    Humanscarriers versus noncarriersfemales

    The effects of genetic polymorphisms of APOE on circulating lipid levels in middle-aged and elderly chinese Fujian Han population: toward age- and sex-personalized management

    Lipids in health and disease

Associations

70

Mortality

upin humans3downin humans1HR 0.977–4.33

3 studies
  1. HDL-C is associated with mortality in humans (Extremely low HDL-C (<20 mg/dL) compared with markedly low HDL-C (20–29 mg/dL)) (29.4% vs. 11.6%; HR 4.33, 95% CI 1.58–11.91).

    “all-cause mortality was higher in the extremely low HDL-C group (29.4% vs. 11.6%; hazard ratio, 4.33; 95% CI, 1.58–11.91; p = 0.004)”

    HumansExtremely low HDL-C (<20 mg/dL) compared with markedly low HDL-C (20–29 mg/dL)median 2.57 years68.9% malesn = 164

    Prevalence, clinical characteristics, and etiologic spectrum of extremely low levels of high-density lipoprotein cholesterol in Thai patients: a single-center study

    Annals of medicine

  2. HDL-C predicts mortality in humans (hospitalized) (AUC 0.67 (95% CI 0.60-0.74)).

    “the area under the curve value was 0.67 (95% CI 0.60-0.74) and the cut-off value of HDL-C was 31 mg/dL.”

    Humanshospitalized30 daysn = 493

    A Low Level of High-Density Lipoprotein Cholesterol Predicts All-Cause Mortality Within 30 Days in Hospitalized Elderly Patients

    Cureus

  3. HDL-C is linked with a lower risk of mortality in humans (hospitalized) (HR 0.977, 95% CI 0.955-0.998).

    “In a multivariate model, the HDL-C showed a hazard ratio of 0.977 (95% confidence interval (CI) 0.955-0.998).”

    Humanshospitalized30 daysn = 493

    A Low Level of High-Density Lipoprotein Cholesterol Predicts All-Cause Mortality Within 30 Days in Hospitalized Elderly Patients

    Cureus

  4. HDL-C is linked with a higher risk of mortality in humans (HR: 1.10, 95% CI: 1.05,1.16).

    “The risk of all-cause and CVD mortality in participants in the fourth quartile group compared with those in the second HDL-C quartile group was (HR: 1.10, 95% CI: 1.05,1.16)”

    Humansn = 69,068

    Association of triglyceride-glucose index, low and high-density lipoprotein cholesterol with all-cause and cardiovascular disease mortality in generally Chinese elderly: a retrospective cohort study

    Frontiers in endocrinology

Alzheimer's disease

upin humans2downin silico1OR 0.51–3

3 studies
  1. HDL-C is associated with Alzheimer's disease in humans (OR 1.09, 95% CI 1.00-1.19).

    “Genetically predicted high-density lipoprotein cholesterol (HDL-C) showed only a nominal association with Alzheimer disease (odds ratio 1.09, 95% confidence interval 1.00-1.19; P = 0.0459)”

    Humans

    Global, Regional and National burden of dementia attributable to metabolic dysregulation from 1990 to 2021, with projections of burden to 2050: An analysis of the global burden of disease study 2021

    Diabetes & metabolic syndrome

  2. HDL-C is associated with Alzheimer's disease in humans (lower longitudinal trajectories) (OR = 3.0, 95% CI = 1.6-5.7).

    “Lower HDL-C trajectories (OR = 3.0, 95% CI = 1.6-5.7) and the lowest VIM quintile of total cholesterol (OR = 2.4, 95% CI = 1.5-3.9) were associated with higher AD risk.”

    Humanslower longitudinal trajectoriesblooddecade prior to first cognitive symptoms

    Lipid Trajectories Improve Risk Models for Alzheimer's Disease and Mild Cognitive Impairment

    medRxiv : the preprint server for health sciencesPreprint

  3. HDL-C lowers the risk of Alzheimer's disease in silico (OR = 0.51, 95% CI 0.29-0.89, p = 0.019).

    “MR analyses indicated a protective association between genetically predicted HDL-C and Alzheimer's disease risk (OR = 0.51, 95% CI 0.29-0.89, p = 0.019).”

    In silico

    Investigating causal effects of HDL-C on cognitive function through cross-sectional and Mendelian randomization analyses: concentration-response patterns and clues for Alzheimer's disease prevention

    BioData mining

More on Alzheimer's disease

Sleep duration

downin humans2

2 studies
  1. Sleep duration is associated with HDL-C in humans with insomnia symptoms (p < 0.05).

    “participants who slept longer (>8 h/day) or shorter (<6 h/day) periods of time with insomnia symptoms had significantly increased ORs of low HDL-C in all models (p < 0.05)”

    Humanswith insomnia symptoms

    Association of Sleep Duration and Self-Reported Insomnia Symptoms with Metabolic Syndrome Components among Middle-Aged and Older Adults

    International journal of environmental research and public health

  2. HDL-C is associated with sleep duration in humans (β2 = -0.006, P = 0.002).

    “HDL-cholesterol was negatively associated with sleep duration 4 year later (β2 = -0.006, P = 0.002).”

    Humans4 yearn = 5,016

    The Relationship Between Sleep Duration and Blood Lipids Among Chinese Middle-Aged and Older Adults: Cross-Lagged Path Analysis From CHARLS

    Frontiers in public health

  3. Sleep duration is associated with HDL-C in humans (β1 = -0.171, P = 0.005).

    “Sleep duration was negatively associated with HDL-cholesterol 4 year later (β1 = -0.171, P = 0.005)”

    Humans4 yearn = 5,016

    The Relationship Between Sleep Duration and Blood Lipids Among Chinese Middle-Aged and Older Adults: Cross-Lagged Path Analysis From CHARLS

    Frontiers in public health

More on Sleep duration

Cardiovascular mortality

upin humans2HR 1.52–1.583

2 studies
  1. HDL-C is linked with a higher risk of cardiovascular mortality in humans (adjusted HR: 1.52; 95% CI 1.04-2.24).

    “Multivariable analysis revealed that very high HDL-C was associated with increased cardiovascular mortality (adjusted HR: 1.52; 95% CI 1.04-2.24; p = 0.03).”

    Humans5.9 years

    Association between very high HDL-C levels and cardiovascular mortality

    European journal of medical research

  2. HDL-C is associated with cardiovascular mortality in humans (HDL-C concentration of 20 mg/dL) (HR 1.583 at HDL-C 20 mg/dL).

    “At the extremes, HR reached 1.583 at 20 mg/dL (low HDL risk)”

    ReviewHDL-C concentration of 20 mg/dL

    The Toxicity of 'Good' Cholesterol: A Restricted Cubic Spline Mapping the Non-Linear U-Shaped Cardiovascular Mortality Curve of Continuous HDL-C

    AHA Scientific Sessions 2026 abstract

Cognitive function

mixedin humans1upin humans1

2 studies
  1. HDL-C is associated with cognitive function in humans (inverted U-shaped relationship).

    “Further concentration-response analyses revealed a linear positive association in men and an inverted U-shaped relationship in women.”

    Humansfemalesn = 2,777

    Investigating causal effects of HDL-C on cognitive function through cross-sectional and Mendelian randomization analyses: concentration-response patterns and clues for Alzheimer's disease prevention

    BioData mining

  2. HDL-C is associated with cognitive function in humans (dementia-free older adults) (B = 0.130, 95% CI: 0.001-0.261, p = 0.049).

    “and global cognition (B = 0.130, 95% CI: 0.001-0.261, p = 0.049).”

    Humansdementia-free older adultsn = 196

    High-Density Lipoprotein Cholesterol and Cognitive Function in Older Korean Adults Without Dementia: Apolipoprotein E4 as a Moderating Factor

    Nutrients

Cognitive impairment

upin humans2OR 1.02

2 studies
  1. Cognitive impairment is associated with HDL-C in humans (β = -0.036 for baseline cognition; P < 0.05).

    “The analysis revealed unidirectional effects of baseline impaired cognition and greater severity of depression on increased HDL-C levels at follow-up”

    Humans4 yearsn = 4,302

    Cognitive impairment and depression precede increased HDL-C levels in middle-aged and older Chinese adults: cross-lagged panel analyses

    Lipids in health and disease

  2. HDL-C is associated with cognitive impairment in humans (primary care) (OR=1.02, 95% CI 1.01-1.04, P=0.011).

    “Logistic regression showed that HDL-c (OR=1.02 [IC=95%; 1.01-1.04]; P=0.011), and age (OR=1.05 [IC=95%; 1.02-1.08]; P=0.004) are independent factors associated with CI.”

    Humansprimary caren = 424

    Inflammation, Oxidation, Caloric Expenditure and Cognitive Impairment in Brazilian Elderly Assisted at Primary Care

    Current Alzheimer research

More on Cognitive impairment

Age

upin humans2

2 studies
  1. HDL-C is associated with age in humans (longevity group only) (r = 0.213, p < 0.001).

    “Scatter plot showed a moderately strong linear relationship between the HDL-C level and age in longevity group (r = 0.213, p < 0.001).”

    Humanslongevity group only

    Positive association of familial longevity with the moderate-high HDL-C concentration in Bama Aging Study

    Aging

  2. Age is associated with HDL-C in humans.

    “and HDL-C increased”

    Humans

    Higher prevalence of elevated LDL-C than non-HDL-C and low statin treatment rate in elderly community-dwelling Chinese with high cardiovascular risk

    Scientific reports

Cancer

upin humans1+29%

1 study
  1. HDL-C is associated with cancer in humans (Extremely low HDL-C (<20 mg/dL); active malignancy) (29.4%).

    “Extremely low HDL-C was more frequently associated with liver disease (41.2%) and active malignancy (29.4%)”

    HumansExtremely low HDL-C (<20 mg/dL); active malignancy

    Prevalence, clinical characteristics, and etiologic spectrum of extremely low levels of high-density lipoprotein cholesterol in Thai patients: a single-center study

    Annals of medicine

More on Cancer

Liver disease

upin humans1+41%

1 study
  1. HDL-C is associated with liver disease in humans (Extremely low HDL-C (<20 mg/dL)) (41.2%).

    “Extremely low HDL-C was more frequently associated with liver disease (41.2%) and active malignancy (29.4%)”

    HumansExtremely low HDL-C (<20 mg/dL)

    Prevalence, clinical characteristics, and etiologic spectrum of extremely low levels of high-density lipoprotein cholesterol in Thai patients: a single-center study

    Annals of medicine

More on Liver disease

Perceived caregiving difficulty

downin humans1

1 study
  1. Perceived caregiving difficulty is associated with HDL-C in humans (Indirect B = -.025, 95% CI: -.059, -.001).

    “of caregiving difficulty on HDL-C through self-care adherence (B = -.025, 95% CI: -.059, -.001)”

    HumansRural caregivers of patients with chronic illness; indirect association through self-care adherence77.7% femalesn = 283

    The Mediating Role of Self-Care Adherence in the Association Between Caregiving Burden and Lipid Profiles Among Rural Caregivers of Patients with Chronic Illness

    AHA Scientific Sessions 2026 abstract

More on Perceived caregiving difficulty

APOB

downin humans1

1 study
  1. APOB is associated with HDL-C in hypercholesterolemic adults treated with rosuvastatin 20 mg for 3 months (β = -0.121, P = .004).

    “lower posttreatment HDL-C (β = -0.121; P = .004)”

    Human trialin hypercholesterolemic adults treated with rosuvastatin 20 mg for 3 months3 monthsn = 79

    Preliminary Evidence for the Association of APOB rs1042034 With Short-Term Statin-Induced Lipid Lowering: An Exploratory Study in Vietnam

    Journal of cardiovascular pharmacology and therapeutics

More on APOB

Patient-reported physical health

downin humans1

1 study
  1. Patient-reported physical health is associated with HDL-C in humans across all participants following lifestyle interventions (ρ=-0.50, adjusted p = 1.00).

    “Improvements in patient-reported physical health were associated with reductions in HDL-c, ApoA1 concentrations, and medium HDLp”

    Human trialacross all participants following lifestyle interventionsn = 20

    The impact of lifestyle modification on metabolic pathways in older adults with overweight/obesity and rheumatoid arthritis: a secondary exploratory analysis of the SWET-RA study

    BMC rheumatology

Cholesterol efflux capacity

upin humans1

1 study
  1. Cholesterol efflux capacity is associated with HDL-C in dyslipidemia, CoQ10 group (r, 0.30).

    “A positive correlation was found between the changes in CEC and HDL cholesterol in the CoQ10 group (r, 0.30; P = 0.032).”

    Human trialin dyslipidemia, CoQ10 group120 mg/d24 wkn = 51

    Coenzyme Q10 supplementation improves cholesterol efflux capacity and antiinflammatory properties of high-density lipoprotein in Chinese adults with dyslipidemia

    Nutrition (Burbank, Los Angeles County, Calif.)

More on Cholesterol efflux capacity

Low-intensity aerobic training

upin humans1

1 study
  1. Low-intensity aerobic training is associated with HDL-C in humans (healthy) (r = .75, P < .01).

    “In addition, the total weekly exercise duration also showed a significant positive relationship with HDL-C (r = .75, P < .01), HDL2-C (r = .81, P < .01)”

    Human trialhealthy5 monthsn = 20

    Effects of low-intensity aerobic training on the high-density lipoprotein cholesterol concentration in healthy elderly subjects

    Metabolism: clinical and experimental

More on Low-intensity aerobic training

All 70

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Higher HDL-C is associated with lower coronary disease risk but higher fracture and mortality risks in human studies; cognitive associations point both ways, including an inverted-U relationship in women. Human trials report HDL-C increases with obicetrapib and walking in women; time-restricted feeding shows an increase in women but no overall change.

  2. Summary rewritten as its findings changed.

    As it read before

    Human studies report differing associations for HDL-C: one reports protection against subclinical carotid atherosclerosis in prediabetes, another links it to Alzheimer’s disease, and another reports increased colorectal adenomatous polyp recurrence after polypectomy. A human preprint links air pollution to HDL-C.

  3. Summary written from the findings.

Latest

Dec 2025: 26Jan 2026: 83Feb 2026: 98Mar 2026: 75Apr 2026: 18May 2026: 14Jun 2026: 20Jul 2026: 42Aug 2026: 57Sep 2026: 65Oct 2026: 105Nov 2026: 63666 papers in 12 months

See all 1,544 papers on HDL-C